These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2694011)

  • 1. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymopentin in chronic Trichophyton rubrum infection.
    Molin L; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin (TP-5) therapy during lymphadenopathy syndrome (LAS/ARC): preliminary report.
    Costigliola P; Ricchi E; Colangeli V; Pintori C; Boni P; Chiodo F
    J Exp Pathol; 1987; 3(4):705-12. PubMed ID: 3331653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
    DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
    Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
    Faist E; Riedel A; Bolla K
    Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
    G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymopentin in the treatment of alopecia areata.
    Orecchia G
    Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thymopentin in the treatment of cutaneous melanoma].
    Trevisan G; Agolzer A
    G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results on clinical and immunological effects of thymopentin in AIDS.
    Clumeck N; van de Perre P; Mascart-Lemone F; Cran S; Bolla K; Duchateau J
    Int J Clin Pharmacol Res; 1984; 4(6):459-63. PubMed ID: 6398315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thymopentin in the treatment of recurrent condylomata acuminata].
    Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
    Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
    Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
    Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of the CD4/CD8 lymphocyte ratio and increased B lymphocytes in long standing diabetic patients following therapy with thymopentin.
    Pozzilli P; Visalli N; Cavallo MG; Beales P; Negri M; Ghirlanda G; Papa V; Andreani D
    Diabetes Res; 1987 Oct; 6(2):51-6. PubMed ID: 2962799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
    Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
    G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymopentin treatment in genital warts of long duration.
    Fransen L; Anthoons J; Hoogewijs G; Bolla K
    Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L; Felici W; Greco L; Mechelli A
    Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic and cytologic aspects of Hashimoto's thyroiditis during therapy with thymopentin].
    Aiello A; Cristofaro M; Carrozza F; Di Rienzo G; Carile L
    Clin Ter; 1990 May; 133(4):227-31. PubMed ID: 2142910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with thymopentin in the treatment of periarthritis humeroscapularis, tendinitis, and gonarthrosis by local infiltration.
    Pipino F; Vittore D
    Arzneimittelforschung; 1988 Jan; 38(1):116-9. PubMed ID: 3284530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.